Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golotimod for Oral Mucositis in Head and Neck Cancer
NCT01247246Phase 2Unknown
- Sponsor
- SciClone Pharmaceuticals (Holdings) Limited
- Start
- Dec 2010
- Primary completion
- Jun 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of golotimod in oral mucositis (OM), sponsored by SciClone Pharmaceuticals (Holdings) Limited. Status: unknown.
02
Drugs
golotimod
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT01247246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01247246.